Source: Global Covid Summit

video

Dr. Richard Urso says we cannot use a one-size fits all approach to fighting Covid.

Dr. Richard Urso is a scientist, sole inventor of an FDA-approved wound healing drug, and the Former Director of Orbital Oncology at MD Anderson Cancer Center. He believes we cannot use a one-size-fits-all approach to fighting Covid.

“We are not going to vaccinate our way out of this,” he said. “There’s no reason to not use anti-inflammatories against inflammatory disease. I used steroids in March and people were saying, ‘Why are you using steroids for inflammatory for this viral disease?’ And I said, ‘Because it’s not a viral disease.’”

Urso says mass lockdowns and waiting for a vaccine never made a lot of sense to him. He calls for a multi-pronged strategy includes targeted vaccination programs, but also early treatment and prevention measures.

Early treatment should have been part of the equation. I’m not against all those other things. Contagion control is important. Washing our hands. Things like that. They’re all important. Do we need vaccination programs? Absolutely. Do we need early treatment programs? Absolutely. So we have basically put the cart before the horse. The tail is wagging the dog. Early treatment should be a mainstay for everything.”



The Early Treatment of Delta: Part 4 – Dr Richard Urso

Covid-19, Early Treatment, and America’s Frontline Doctors – The Dr Urso Interview

Hydroxychloroquine is the smartest drug in history

How hydroxychloroquine works at the cellular level

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19 infection includes HCQ & Ivermectin

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »